Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11357217 Humanized universal light chain mice

Patent 11357217 was granted and assigned to Regeneron Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Date Filed
October 2, 2018
Date of Patent
June 14, 2022
Patent Application Number
16149838
Patent Citations
‌
US Patent 10577430 ADAM6 mice
0
‌
US Patent 10412940 Mice expressing a limited immunoglobulin light chain repertoire
‌
US Patent 10072095 ADAM6 mice
0
‌
US Patent 10143186 Common light chain mouse
‌
US Patent 10167344 Mice expressing a limited immunoglobulin light chain repertoire
‌
US Patent 10130081 Humanized universal light chain mice
0
‌
US Patent 10905109 ADAM6 mice
‌
US Patent 10905108 ADAM6 mice
0
‌
US Patent 10694725 ADAM6 mice
0
Patent Citations Received
‌
US Patent 11559050 Humanized non-human animals with restricted immunoglobulin heavy chain loci
0
‌
US Patent 11666040 Humanized non-human animals with restricted immunoglobulin heavy chain loci
0
Patent Inventor Names
Andrew J. Murphy
0
Sean Stevens
0
Margaret Karow
0
Lynn Macdonald
0
John McWhirter
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11357217
Patent Primary Examiner
‌
Anne Marie S. Wehbe′

Find more entities like US Patent 11357217 Humanized universal light chain mice

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.